ALEC - Alector, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.05 0.11 (3.61%)	---	---	---	-0.09 (-2.95%)	0.29 (10.0%)	0.0 (0.0%)	0.0 (0.0%)

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.3
Diluted EPS:: -0.3
Basic P/E:: -10.5333
Diluted P/E:: -10.5333
RSI(14) 1m:: 0.0
VWAP:: 3.16
RVol:: 1.4819

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.04 +0.04 (+1.17%)	Oct 15 09:35
1m	Price increase 1m	2.99 +0.07 (+2.4%)	Oct 15 09:33
10m	Price increase 10m	2.99 +0.09 (+3.1%)	Oct 15 09:33
1m	Price increase 1m	2.92 +0.03 (+1.04%)	Oct 15 09:32